Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




FLT-PET Imaging Superior to Bone-Marrow Biopsy for Assessing Treatment Response in Leukemia
Link ID 7413
Title FLT-PET Imaging Superior to Bone-Marrow Biopsy for Assessing Treatment Response in Leukemia
Url http://www.medscape.com/viewarticle/578566?src=rss
Description FLT-PET imaging may be able to determine treatment response among adult leukemia patients after only 1 day of chemotherapy, which can improve disease management and spare patients from ineffective chemotherapy Medscape Medical News
Category Articles > Hematology-Oncology
Keywords
Date Aug 5, 2008
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Hematology-Oncology
1. NCCN 2nd Annual Congress: Hematologic Malignancies - Transfusion Support and Iron Overload in Myelod
  What are some of the risks and complications of iron overload and how can they be avoided?
Category:   Articles > Hematology-Oncology


2. Refining First-line Treatment for Metastatic Breast Cancer
  How do the experts take tumor biology, efficacy and safety data, and patient preferences into account to optimize treatment for metastatic breast cancer? Medscape Hematology-Oncology
Category:   Articles > Hematology-Oncology


3. FLT-PET Imaging Superior to Bone-Marrow Biopsy for Assessing Treatment Response in Leukemia
  FLT-PET imaging may be able to determine treatment response among adult leukemia patients after only 1 day of chemotherapy, which can improve disease management and spare patients from ineffective chemotherapy Medscape Medical News
Category:   Articles > Hematology-Oncology


4. Adjuvant Therapy for HER2-Positive Breast Cancer: An Expert Interview With Dr. Harold Burstein
  What do clinicians need to know in 2008? Dr. Harold Burstein brings readers up to date about trastuzumab-based regimens, selecting a chemotherapy backbone, and monitoring cardiac function.
Medscape Hematology-Oncology
Category:   Articles > Hematology-Oncology


5. Zevalin Improves Progression-Free Survival by 2 Years in Follicular Lymphoma
  Dramatic results showing that radioimmunotherapy with Zevalin prolongs progression-free survival by 2 years come just days after cuts in reimbursement for this therapy were announced in the United States. Medscape Medical News
Category:   Articles > Hematology-Oncology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS